Search

Author/Creator Goldschmidt, Jerome

1. Atezolizumab in patients with advanced non-small cell lung cancer and history of asymptomatic, treated brain metastases: Exploratory analyses of the phase III OAK study. (February 2019)

Authors:
Gadgeel, Shirish M.; Lukas, Rimas V.; Goldschmidt, Jerome; Conkling, Paul; Park, Keunchil; Cortinovis, Diego; de Marinis, Filippo; Rittmeyer, Achim; Patel, Jyoti D.; von Pawel, Joachim; O'Hear, Carol; Lai, Catherine; Hu, Sylvia; Ballinger, Marcus; Sandler, Alan; Gandhi, Mayank; Fehrenbacher, Lou
Journal:
Lung cancer
Issue:
Volume 128(2019)
Page Start:
105
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Phase 2, randomized, open‐label study of ramucirumab in combination with first‐line pemetrexed and platinum chemotherapy in patients with nonsquamous, advanced/metastatic non–small cell lung cancer. Issue 6 (6th November 2014)

Authors:
Doebele, Robert C.; Spigel, David; Tehfe, Mustapha; Thomas, Sachdev; Reck, Martin; Verma, Sunil; Eakle, Janice; Bustin, Frederique; Goldschmidt, Jerome; Cao, Dachuang; Alexandris, Ekaterine; Yurasov, Sergey; Camidge, D. Ross; Bonomi, Philip
Journal:
Cancer
Issue:
Volume 121:Issue 6(2015)
Page Start:
883
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Trilaciclib prior to chemotherapy and atezolizumab in patients with newly diagnosed extensive‐stage small cell lung cancer: A multicentre, randomised, double‐blind, placebo‐controlled Phase II trial. Issue 10 (12th January 2021)

Authors:
Daniel, Davey; Kuchava, Vladimer; Bondarenko, Igor; Ivashchuk, Oleksandr; Reddy, Sreekanth; Jaal, Jana; Kudaba, Iveta; Hart, Lowell; Matitashvili, Amiran; Pritchett, Yili; Morris, Shannon R.; Sorrentino, Jessica A.; Antal, Joyce M.; Goldschmidt, Jerome
Journal:
International journal of cancer
Issue:
Volume 148:Issue 10(2021)
Page Start:
2557
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗